Understanding how a specific protein affects brain development in DYT6 dystonia
Role of DYT6 Dystonia Protein THAP1 in Oligodendroglial Mediated ECM Homeostasis During CNS Development
This work explores how a protein called THAP1, linked to DYT6 dystonia, helps shape the brain's support system during development.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11127427 on NIH RePORTER |
What this research studies
Our brains have a complex support network called the extracellular matrix (ECM) that is crucial for how brain cells connect and communicate. We are learning more about how this ECM is built during brain development, especially focusing on a protein called THAP1. This protein is important for the cells that create myelin, a protective layer around nerve fibers, and when THAP1 is faulty, it can lead to a movement disorder called DYT6 dystonia. This project aims to uncover the exact steps by which THAP1 controls the ECM and myelin formation, which could help us understand the root causes of this condition.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients but focuses on understanding the biological mechanisms relevant to individuals with DYT6 dystonia.
Not a fit: Patients without DYT6 dystonia or related neurodevelopmental movement disorders may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to a deeper understanding of DYT6 dystonia and potentially new ways to address the underlying brain changes.
How similar studies have performed: The hypothesis that specific brain cells regulate the extracellular matrix is new, making this a novel approach to understanding brain development and dystonia.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Yellajoshyula, Dhananjay — Case Western Reserve University
- Study coordinator: Yellajoshyula, Dhananjay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.